Assignee
ANNOVIS BIO INC
US·9 granted patents·8 pending applications·3 citations·filing 2016–2025
Top patents by PatentIndex Score
17 records- 0189US11596621B2Prevention or treatment of disease states due to metal dis-homeostasis via administration of Posiphen to healthy or sick humansANNOVIS BIO INC·Filed 2020·Granted Mar 7, 2023·2 cites·15 claims
- 0289US2025114330A1(3ar)-1,3a,8-trimethyl-1 ,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate and methods of treating or preventing neurodegenerationANNOVIS BIO INC·Filed 2024·Application pending·0 cites
- 0386US11382893B2(3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate and methods of treating or preventing neurodegenerationANNOVIS BIO INC·Filed 2020·Granted Jul 12, 2022·1 cites·15 claims
- 0482US12390448B2Prevention or of disease states due to metal dis-homeostasis via administration of posiphen to healthy or sick humansANNOVIS BIO INC·Filed 2023·Granted Aug 19, 2025·0 cites·20 claims
- 0582US12144798B2(3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8ahexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate and methods of treating or preventing neurodegenerationANNOVIS BIO INC·Filed 2022·Granted Nov 19, 2024·0 cites·20 claims
- 0682US2025360104A1Prevention or treatment of disease states due to metal dis-homeostasisANNOVIS BIO INC·Filed 2025·Application pending·0 cites
- 0777US11096926B2(3AR)-1,3A,8-trimethyl-1,2,3,3A,8,8A-hexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate and methods of treating or preventing neurodegenerationANNOVIS BIO INC·Filed 2019·Granted Aug 24, 2021·0 cites·18 claims
- 0877US2025025444A1Treatment of neurodegenerative diseases via administration of buntanetap and a phosphodiesterase inhibitorANNOVIS BIO INC·Filed 2024·Application pending·0 cites
- 0974US2025000846A1Methods of treatment or prevention of acute brain or nerve injuriesANNOVIS BIO INC·Filed 2024·Application pending·0 cites
- 1073US11400075B2(3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate and methods of treating or preventing neurodegenerationANNOVIS BIO INC·Filed 2020·Granted Aug 2, 2022·0 cites·19 claims
- 1173US11376238B2(3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate and methods of treating or preventing neurodegenerationANNOVIS BIO INC·Filed 2020·Granted Jul 5, 2022·0 cites·19 claims
- 1267US2025235429A1Treatment of diseases via administration of buntanetap and an antidiabetic agentANNOVIS BIO INC·Filed 2024·Application pending·0 cites
- 1367US2025319068A1Treatment of diseases via administration of buntanetap and an antihypertensive agentANNOVIS BIO INC·Filed 2024·Application pending·0 cites
- 1467US2026062418A1Solid forms of posiphen d-tartrateANNOVIS BIO INC·Filed 2025·Application pending·0 cites
- 1565US12582632B2Inhibition of neurological injuries due to infections via administration of Butanetap and analogs thereofANNOVIS BIO INC·Filed 2022·Granted Mar 24, 2026·0 cites·16 claims
- 1662US2024252467A1Treatment of mental illness via administration of buntanetap and analogues thereofANNOVIS BIO INC·Filed 2024·Application pending·0 cites
- 1758US12042482B2Methods of treatment or prevention of acute brain or nerve injuriesANNOVIS BIO INC·Filed 2016·Granted Jul 23, 2024·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when ANNOVIS BIO INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →